王志章，2017年在上海交通大学医学院获博士学位，2017-2019年在中国科学院上海生命科学研究院从事博士后研究。2019年1月加入南方医科大学南方医院，任病理科及广东省分子肿瘤病理重点实验室教授、博士生导师。主要从事免疫代谢与细胞因子转录后调控机制的研究，在Immunity、EMBO Journal等杂志发表论文多篇。课题组主要利用自身免疫及肿瘤免疫动物模型，结合小分子药物高通量筛选及CRISPR基因编辑筛选，系统研究RNA结合蛋白介导的转录后调控机制在免疫代谢调节及相关疾病中的作用。

邮箱：wangzhizhang_2006@163.com

 

Dr. Zhizhang Wang received his Ph.D degree from School of Medicine, Shanghai Jiao Tong University in 2017. He then worked as a Postdoc at Shanghai Institutes of Biological Science, Chinese Academy of Science from 2017 to 2019. Starting in 2019, he joined the Department of Pathology in Nanfang Hospital, Guangdong Molecular Tumor Pathology Key Laboratory as an independent principle investigator. Studying the molecular mechanism of immunometabolism and posttranscriptional regulation of cytokine for several years，Dr. Wang has published several papers in high-profile journals including Immunity,EMBO Journal. Using animal model of autoimmune disease and cancer immunotherapy, along with high-throughput screening with small molecule drug and genome editing, His lab will systematically analyze the function and mechanism of RNA binding proteins mediated posttranscriptional regulation in related disease.

Email: wangzhizhang_2006@163.com